164 related articles for article (PubMed ID: 16420784)
1. [Antiangiogenic treatment of cancer].
Mauriz JL; Linares P; González P; Culebras JM
Cir Esp; 2005 Jul; 78(1):3-11. PubMed ID: 16420784
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis research. Cancer drugs found to work in new way.
Barinaga M
Science; 2000 Apr; 288(5464):245. PubMed ID: 10777399
[No Abstract] [Full Text] [Related]
3. Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis.
Stoeltzing O; Liu W; Reinmuth N; Parikh A; Ahmad SA; Jung YD; Fan F; Ellis LM
Ann Surg Oncol; 2003 Aug; 10(7):722-33. PubMed ID: 12900362
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of the anti-angiogenesis drug TNP-470.
Gervaz P; Fontolliet C
Int J Exp Pathol; 1998 Dec; 79(6):359-62. PubMed ID: 10319017
[TBL] [Abstract][Full Text] [Related]
5. TNP-470: an angiogenesis inhibitor in clinical development for cancer.
Kruger EA; Figg WD
Expert Opin Investig Drugs; 2000 Jun; 9(6):1383-96. PubMed ID: 11060750
[TBL] [Abstract][Full Text] [Related]
6. General aspects of anti-angiogenesis and cancer therapy.
Zogakis TG; Libutti SK
Expert Opin Biol Ther; 2001 Mar; 1(2):253-75. PubMed ID: 11727534
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic potential of prostate carcinoma cells overexpressing bcl-2.
Fernandez A; Udagawa T; Schwesinger C; Beecken W; Achilles-Gerte E; McDonnell T; D'Amato R
J Natl Cancer Inst; 2001 Feb; 93(3):208-13. PubMed ID: 11158189
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of anti-angiogenic tyrosine kinase inhibition on wound healing--the obvious and not so obvious.
McCarty ME; Ellis LM
Cancer Biol Ther; 2002; 1(2):127-9. PubMed ID: 12212612
[No Abstract] [Full Text] [Related]
9. Clinical trials of antiangiogenic agents.
Twardowski P; Gradishar WJ
Curr Opin Oncol; 1997 Nov; 9(6):584-9. PubMed ID: 9370081
[TBL] [Abstract][Full Text] [Related]
10. Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice.
Beecken WD; Fernandez A; Joussen AM; Achilles EG; Flynn E; Lo KM; Gillies SD; Javaherian K; Folkman J; Shing Y
J Natl Cancer Inst; 2001 Mar; 93(5):382-7. PubMed ID: 11238700
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis research yields new approaches to cancer treatment and prognosis.
Larsen NS
J Natl Cancer Inst; 1993 Oct; 85(20):1629-30. PubMed ID: 7692073
[No Abstract] [Full Text] [Related]
12. Hitting the mother lode of tumor angiogenesis.
James D; Rabbany S; Rafii S
Nat Biotechnol; 2008 Jul; 26(7):769-70. PubMed ID: 18612297
[No Abstract] [Full Text] [Related]
13. Simulation of human B-lymphocyte proliferation by AGM-1470, a potent inhibitor of angiogenesis.
Antoine N; Bours V; Heinen E; Simar LJ; Castronovo V
J Natl Cancer Inst; 1995 Jan; 87(2):136-9. PubMed ID: 7535858
[No Abstract] [Full Text] [Related]
14. Carcinosarcoma-induced endothelial cells tube formation through KDR/Flk-1 is blocked by TNP-470.
Miura S; Emoto M; Matsuo Y; Kawarabayashi T; Saku K
Cancer Lett; 2004 Jan; 203(1):45-50. PubMed ID: 14670616
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic treatment for peritoneal dissemination of pancreas adenocarcinoma: a study using TNP-470.
Kato H; Ishikura H; Kawarada Y; Furuya M; Kondo S; Kato H; Yoshiki T
Jpn J Cancer Res; 2001 Jan; 92(1):67-73. PubMed ID: 11173546
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen-induced prolactinoma in Fischer 344 rats.
Stepień H; Grochal M; Zieliński KW; Mucha S; Kunert-Radek J; Kulig A; Stawowy A; Pisarek H
J Endocrinol; 1996 Jul; 150(1):99-106. PubMed ID: 8708569
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of angiogenesis in a clinical perspective.
Voest EE
Anticancer Drugs; 1996 Sep; 7(7):723-7. PubMed ID: 8949981
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y
Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337
[TBL] [Abstract][Full Text] [Related]
19. TNP-470 (AGM-1470): mechanisms of action and early clinical development.
Castronovo V; Belotti D
Eur J Cancer; 1996 Dec; 32A(14):2520-7. PubMed ID: 9059342
[No Abstract] [Full Text] [Related]
20. Broad spectrum antiangiogenic treatment for ocular neovascular diseases.
Benny O; Nakai K; Yoshimura T; Bazinet L; Akula JD; Nakao S; Hafezi-Moghadam A; Panigrahy D; Pakneshan P; D'Amato RJ
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
